{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:37:48Z","timestamp":1772120268053,"version":"3.50.1"},"reference-count":199,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":189,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2P41GM103504-11"],"award-info":[{"award-number":["2P41GM103504-11"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA248138"],"award-info":[{"award-number":["U24CA248138"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"Mark Foundation For Cancer Research","doi-asserted-by":"publisher","award":["18-022-ELA"],"award-info":[{"award-number":["18-022-ELA"]}],"id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000085","name":"Directorate for Geosciences","doi-asserted-by":"publisher","award":["GSE78220"],"award-info":[{"award-number":["GSE78220"]}],"id":[{"id":"10.13039\/100000085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016477","name":"CareDx","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["T15LM011271"],"award-info":[{"award-number":["T15LM011271"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005976","name":"Harry J. Lloyd Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 CA220009"],"award-info":[{"award-number":["RO1 CA220009"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH122688-02"],"award-info":[{"award-number":["R01 MH122688-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ajhg.2023.05.013","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T10:32:07Z","timestamp":1687170727000},"page":"1138-1161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autoimmune alleles at the major histocompatibility locus modify melanoma susceptibility"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-1950","authenticated-orcid":false,"given":"James V.","family":"Talwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Laub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghana S.","family":"Pagadala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"McKenna","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg E.","family":"Luebeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan R.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick N.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriacos","family":"Markianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig C.","family":"Teerlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hauger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiju","family":"Pyarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald P.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rany M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley K.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kit","family":"Curtius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1729-2463","authenticated-orcid":false,"given":"Hannah","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajhg.2023.05.013_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejcsup.2013.07.012","article-title":"Melanoma epidemiology, biology and prognosis","volume":"11","author":"Ali","year":"2013","journal-title":"EJC Suppl."},{"key":"10.1016\/j.ajhg.2023.05.013_bib2","series-title":"Cutaneous Melanoma: Etiology and Therapy","first-page":"3","article-title":"Epidemiology of Melanoma","author":"Matthews","year":"2018"},{"key":"10.1016\/j.ajhg.2023.05.013_bib3","unstructured":"Howlader, N., Noone, A.M., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D.R., et\u00a0al (eds) SEER Cancer Statistics Review, 1975-2017. National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2017\/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020."},{"key":"10.1016\/j.ajhg.2023.05.013_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199904293401707","article-title":"The pathogenesis of melanoma induced by ultraviolet radiation","volume":"340","author":"Gilchrest","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.annepidem.2007.01.030","article-title":"Ambient UVB and melanoma risk in the United States: a case-control analysis","volume":"17","author":"Lea","year":"2007","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11912-010-0119-y","article-title":"How sunlight causes melanoma","volume":"12","author":"Garibyan","year":"2010","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ajhg.2023.05.013_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature05660","article-title":"Melanocyte biology and skin pigmentation","volume":"445","author":"Lin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.05.013_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.genet.37.110801.143233","article-title":"Genetics of hair and skin color","volume":"37","author":"Rees","year":"2003","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib9","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/ijc.25243","article-title":"Estimating the attributable fraction for melanoma: a meta-analysis of pigmentary characteristics and freckling","volume":"127","author":"Olsen","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ijc.23869","article-title":"A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes","volume":"124","author":"Chang","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1940-6207.CAPR-09-0108","article-title":"Estimating the attributable fraction for cancer: A meta-analysis of nevi and melanoma","volume":"3","author":"Olsen","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/0003-4819-125-5-199609010-00003","article-title":"A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group","volume":"125","author":"Schuchter","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib13","first-page":"1000129","article-title":"Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors","volume":"2","author":"Williams","year":"2011","journal-title":"J.\u00a0Clin. Exp. Dermatol. Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/jid.2008.238","article-title":"A prospective study of telomere length and the risk of skin cancer","volume":"129","author":"Han","year":"2009","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib15","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1158\/1055-9965.EPI-07-0152","article-title":"Nevus Size and Number Are Associated with Telomere Length and Represent Potential Markers of a Decreased Senescence In\u00a0vivo","volume":"16","author":"Bataille","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ajhg.2023.05.013_bib16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2340\/00015555-2148","article-title":"Increased risk of melanoma in organ transplant recipients: systematic review and meta-analysis of cohort studies","volume":"95","author":"Green","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib17","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(81)92359-X","article-title":"Malignant melanoma in renal-transplant recipients","volume":"1","author":"Greene","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ajhg.2023.05.013_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1055-9965.EPI-09-0928","article-title":"Familial melanoma: a meta-analysis and estimates of attributable fraction","volume":"19","author":"Olsen","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ajhg.2023.05.013_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijc.2910620403","article-title":"Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE)","volume":"62","author":"Ford","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial Risk and Heritability of Cancer Among Twins in Nordic Countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajhg.2023.05.013_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.05.013_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.05.013_bib23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib24","first-page":"158","article-title":"Immunological factors which influence response to immunotherapy in malignant melanoma","volume":"68","author":"Morton","year":"1970","journal-title":"Surgery"},{"key":"10.1016\/j.ajhg.2023.05.013_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cell.2013.08.041","article-title":"Genetic variants regulating immune cell levels in health and disease","volume":"155","author":"Orr\u00f9","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2023.05.013_bib26","doi-asserted-by":"crossref","first-page":"13850","DOI":"10.1038\/ncomms13850","article-title":"Innate and adaptive immune traits are differentially affected by genetic and environmental factors","volume":"8","author":"Mangino","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.05.013_bib27","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41467-020-16097-9","article-title":"Demographic and genetic factors influence the abundance of infiltrating immune cells in human tissues","volume":"11","author":"Marderstein","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.05.013_bib28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib29","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48","author":"Jin","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41588-020-0611-8","article-title":"Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility","volume":"52","author":"Landi","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fimmu.2014.00197","article-title":"Does the immune system naturally protect against cancer?","volume":"5","author":"Corthay","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1189\/jlb.1107774","article-title":"Immune-mediated dormancy: an equilibrium with cancer","volume":"84","author":"Teng","year":"2008","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib33","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrg1944","article-title":"Genetics of autoimmune diseases--disorders of immune homeostasis","volume":"7","author":"Gregersen","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(95)90047-0","article-title":"Induction of anti-self-immunity to cure cancer","volume":"82","author":"Nanda","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2023.05.013_bib35","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1073\/pnas.96.10.5340","article-title":"Inducing autoimmune disease to treat cancer","volume":"96","author":"Pardoll","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2023.05.013_bib36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/gm199","article-title":"The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma","volume":"2","author":"Spritz","year":"2010","journal-title":"Genome Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib37","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/2326-6066.CIR-18-0487","article-title":"The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy","volume":"6","author":"Young","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib38","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00262-019-02318-8","article-title":"Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition","volume":"68","author":"Chat","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ajhg.2023.05.013_bib39","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1073\/pnas.1922867117","article-title":"Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer","volume":"117","author":"Khan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2023.05.013_bib40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/ard.2004.033993","article-title":"Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ajhg.2023.05.013_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ajhg.2023.05.013_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjd.12111","article-title":"Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners","volume":"168","author":"Teulings","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib43","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present Yourself! By MHC Class I and MHC Class II Molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fimmu.2018.00014","article-title":"Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy","volume":"9","author":"Durgeau","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bpj.2015.06.045","article-title":"Design Parameters for Granzyme-Mediated Cytotoxic Lymphocyte Target-Cell Killing and Specificity","volume":"109","author":"Woodsworth","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.ajhg.2023.05.013_bib46","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cell.2017.09.050","article-title":"MHC-I Genotype Restricts the Oncogenic Mutational Landscape","volume":"171","author":"Marty","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2023.05.013_bib47","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.cell.2018.11.050","article-title":"Evolutionary Pressure against MHC Class II Binding Cancer Mutations","volume":"175","author":"Marty Pyke","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2023.05.013_bib48","doi-asserted-by":"crossref","first-page":"e1008227","DOI":"10.1371\/journal.pgen.1008227","article-title":"Quantifying immune-based counterselection of somatic mutations","volume":"15","author":"Yang","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib49","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aao4572","article-title":"Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy","volume":"359","author":"Chowell","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ajhg.2023.05.013_bib50","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41591-019-0639-4","article-title":"Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy","volume":"25","author":"Chowell","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13073-020-00743-4","article-title":"MHC-I genotype and tumor mutational burden predict response to immunotherapy","volume":"12","author":"Goodman","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib52","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2023.05.013_bib53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12920-019-0544-1","article-title":"Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes","volume":"12","author":"Castro","year":"2019","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.ajhg.2023.05.013_bib54","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T\u00a0cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib55","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fimmu.2019.01198","article-title":"Autoreactive T-Lymphocytes in Inflammatory Skin Diseases","volume":"10","author":"Boehncke","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib56","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nm1605","article-title":"\u03b1 1 \u03b2 1 integrin is crucial for accumulation of epidermal T\u00a0cells and the development of psoriasis","volume":"13","author":"Conrad","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib57","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T\u00a0cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib58","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3389\/fimmu.2018.00954","article-title":"Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis","volume":"9","author":"Prinz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib59","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib60","doi-asserted-by":"crossref","first-page":"e23089","DOI":"10.1371\/journal.pone.0023089","article-title":"Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajhg.2023.05.013_bib61","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/CCID.S142819","article-title":"Psoriasis and vitiligo are close relatives","volume":"10","author":"Sharquie","year":"2017","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib62","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4103\/idoj.IDOJ_648_19","article-title":"Association of Psoriasis with Autoimmune Disorders: Results of a Pilot Study","volume":"11","author":"Vashist","year":"2020","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.ajhg.2023.05.013_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","article-title":"Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy","volume":"19","author":"Rosenberg","year":"1996","journal-title":"J.\u00a0Immunother. Emphasis Tumor Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jamadermatol.2015.2707","article-title":"Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab","volume":"152","author":"Hua","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/1346-8138.13520","article-title":"Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi-institutional retrospective study","volume":"44","author":"Nakamura","year":"2017","journal-title":"J.\u00a0Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib66","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00432-018-2819-x","article-title":"Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma","volume":"145","author":"Indini","year":"2019","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib67","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejca.2016.02.025","article-title":"Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy","volume":"60","author":"Hofmann","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib68","first-page":"e254","article-title":"Anti-PD1-induced psoriasis: a study of 21 patients","volume":"31","author":"Bonigen","year":"2017","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib69","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"Shukla","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib70","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/humu.23230","article-title":"HLA-HD: An accurate HLA typing algorithm for next-generation sequencing data","volume":"38","author":"Kawaguchi","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ajhg.2023.05.013_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2023.05.013_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ajhg.2023.05.013_bib73","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.3361","article-title":"Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas","volume":"47","author":"Krauthammer","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib74","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/modpathol.2016.237","article-title":"Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas","volume":"30","author":"Lazova","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib75","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The Genetic Evolution of Melanoma from Precursor Lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib76","first-page":"4145","article-title":"Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma","volume":"27","author":"Gu","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib77","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ajhg.2019.08.012","article-title":"Harmonizing Genetic Ancestry and Self-identified Race\/Ethnicity in Genome-wide Association Studies","volume":"105","author":"Fang","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib78","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nbt.2749","article-title":"Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data","volume":"31","author":"Denny","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/tpj.2013.18","article-title":"HIBAG\u2014HLA genotype imputation with attribute bagging","volume":"14","author":"Zheng","year":"2014","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.ajhg.2023.05.013_bib80","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/hmg\/ddy443","article-title":"Construction and benchmarking of a multi-ethnic reference panel for the imputation of HLA class I and II alleles","volume":"28","author":"Degenhardt","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib81","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ajhg.2020.03.004","article-title":"Genotyping Array Design and Data Quality Control in the Million Veteran Program","volume":"106","author":"Hunter-Zinck","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib82","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib83","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ajhg.2023.05.013_bib84","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nbt.2862","article-title":"Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms","volume":"32","author":"Patro","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib85","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib86","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13059-016-1029-6","article-title":"MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data","volume":"17","author":"Fan","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib88","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","article-title":"SomaticSniper: identification of somatic point mutations in whole genome sequencing data","volume":"28","author":"Larson","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajhg.2023.05.013_bib89","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2023.05.013_bib90","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2023.05.013_bib91","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41588-020-00739-1","article-title":"Integrated molecular drivers coordinate biological and clinical states in melanoma","volume":"52","author":"Conway","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib92","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1158\/0008-5472.CAN-09-1133","article-title":"Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations","volume":"69","author":"Carter","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cels.2019.05.005","article-title":"CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers","volume":"9","author":"Tokheim","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.ajhg.2023.05.013_bib94","doi-asserted-by":"crossref","first-page":"9775","DOI":"10.1073\/pnas.1820006116","article-title":"scMerge leverages factor analysis, stable expression, and pseudoreplication to merge multiple single-cell RNA-seq datasets","volume":"116","author":"Lin","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2023.05.013_bib95","doi-asserted-by":"crossref","first-page":"D394","DOI":"10.1093\/nar\/gkaa1106","article-title":"PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API","volume":"49","author":"Mi","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib96","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib97","series-title":"Bioinformatics for Cancer Immunotherapy: Methods and Protocols","first-page":"101","article-title":"HLApers: HLA Typing and Quantification of Expression with Personalized Index","author":"Aguiar","year":"2020"},{"key":"10.1016\/j.ajhg.2023.05.013_bib98","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib99","doi-asserted-by":"crossref","first-page":"D766","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib100","first-page":"D948","article-title":"IPD-IMGT\/HLA Database","volume":"48","author":"Robinson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib101","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib102","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity","volume":"6","author":"Aran","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.05.013_bib103","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41591-020-0818-3","article-title":"Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy","volume":"26","author":"P\u00e9rez-Guijarro","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib104","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T\u00a0cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib105","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib106","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"GigaScience"},{"key":"10.1016\/j.ajhg.2023.05.013_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1954.1","article-title":"The age distribution of cancer and a multi-stage theory of carcinogenesis","volume":"8","author":"Armitage","year":"1954","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib109","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jnci\/66.6.1037","article-title":"Mutation and cancer: a model for human carcinogenesis","volume":"66","author":"Moolgavkar","year":"1981","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ajhg.2023.05.013_bib110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1539-6924.1988.tb00502.x","article-title":"A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor","volume":"8","author":"Moolgavkar","year":"1988","journal-title":"Risk Anal."},{"key":"10.1016\/j.ajhg.2023.05.013_bib111","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1539-6924.1990.tb01053.x","article-title":"Two-event model for carcinogenesis: biological, mathematical, and statistical considerations","volume":"10","author":"Moolgavkar","year":"1990","journal-title":"Risk Anal."},{"key":"10.1016\/j.ajhg.2023.05.013_bib112","doi-asserted-by":"crossref","first-page":"e1005431","DOI":"10.1371\/journal.pcbi.1005431","article-title":"Parameter estimation for multistage clonal expansion models from cancer incidence data: A practical identifiability analysis","volume":"13","author":"Brouwer","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib113","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1073\/pnas.0801151105","article-title":"Age-specific incidence of cancer: Phases, transitions, and biological implications","volume":"105","author":"Meza","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2023.05.013_bib114","series-title":"Stochastic Models of Carcinogenesis","author":"Tan","year":"2020"},{"key":"10.1016\/j.ajhg.2023.05.013_bib115","unstructured":"SEER Research Data 1975-2018 when Using SEER\u2217Stat: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER\u2217Stat Database: Incidence - SEER Research Data, 9 Registries, Nov 2020 Sub (1975-2018) - Linked To County Attributes - Time Dependent (1990-2018) Income\/Rurality, 1969-2019 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2021, based on the November 2020 submission."},{"key":"10.1016\/j.ajhg.2023.05.013_bib116","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/0008-5472.CAN-12-2198","article-title":"Impact of tumor progression on cancer incidence curves","volume":"73","author":"Luebeck","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib117","doi-asserted-by":"crossref","first-page":"e1008961","DOI":"10.1371\/journal.pcbi.1008961","article-title":"Modeling historic incidence trends implies early field cancerization in esophageal squamous cell carcinoma","volume":"17","author":"Luebeck","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib118","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","article-title":"The evolutionary history of 2,658 cancers","volume":"578","author":"Gerstung","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.05.013_bib119","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib120","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","article-title":"Signatures of copy number alterations in human cancer","volume":"606","author":"Steele","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.05.013_bib121","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/annonc\/mdu479","article-title":"Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data","volume":"26","author":"Favero","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib122","series-title":"Proceedings of the 9th Python in Science Conference","doi-asserted-by":"crossref","first-page":"61","DOI":"10.25080\/Majora-92bf1922-011","article-title":"Statsmodels: Econometric and statistical modeling with python","author":"Seabold","year":"2010"},{"key":"10.1016\/j.ajhg.2023.05.013_bib123","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2014.07.002","article-title":"Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes","volume":"95","author":"Okada","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib124","doi-asserted-by":"crossref","first-page":"e1002514","DOI":"10.1371\/journal.pgen.1002514","article-title":"Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease","volume":"8","author":"Chen","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00439-005-0048-2","article-title":"Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR","volume":"118","author":"Helms","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib126","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.33415","article-title":"HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype","volume":"64","author":"Winchester","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ajhg.2023.05.013_bib127","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","article-title":"Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype","volume":"17","author":"FitzGerald","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ajhg.2023.05.013_bib128","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib129","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib131","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/jid.2012.37","article-title":"Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation","volume":"132","author":"Jin","year":"2012","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib132","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jdermsci.2004.05.003","article-title":"Association of HLA class I alleles with vitiligo in Chinese Hans","volume":"35","author":"Zhang","year":"2004","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.ajhg.2023.05.013_bib133","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ng.603","article-title":"Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC","volume":"42","author":"Quan","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib134","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/503821","article-title":"Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene","volume":"78","author":"Nair","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2133.2003.05115.x","article-title":"Psoriasis patients who are homozygous for the HLA-Cw\u22170602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes","volume":"148","author":"Gudjonsson","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib136","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1346-8138.2005.tb00807.x","article-title":"Psoriasis arthropathy and HLA-B51: report of 5 cases","volume":"32","author":"Yamamoto","year":"2005","journal-title":"J.\u00a0Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib137","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature06406","article-title":"Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A","volume":"450","author":"Nejentsev","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.05.013_bib138","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.2337\/db10-0699","article-title":"HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium","volume":"59","author":"Noble","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ajhg.2023.05.013_bib139","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1463-1326.2008.01001.x","article-title":"Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A","volume":"11","author":"Howson","year":"2009","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ajhg.2023.05.013_bib140","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","article-title":"Close Association of HLA-Bw51 With Behcet\u2019s Disease","volume":"100","author":"Ohno","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib141","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.it.2018.01.001","article-title":"Generalists and Specialists: A New View of How MHC Class I Molecules Fight Infectious Pathogens","volume":"39","author":"Kaufman","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib142","doi-asserted-by":"crossref","first-page":"28232","DOI":"10.1073\/pnas.2013554117","article-title":"HLA tapasin independence: broader peptide repertoire and HIV control","volume":"117","author":"Bashirova","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2023.05.013_bib143","first-page":"D783","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib144","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0142(197707)40:1<389::AID-CNCR2820400155>3.0.CO;2-I","article-title":"Prognosis in malignant melanoma of the skin. Significance of stage of disease, anatomical site, sex, age and period of diagnosis","volume":"40","author":"Magnus","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib145","doi-asserted-by":"crossref","first-page":"e31770","DOI":"10.7554\/eLife.31770","article-title":"Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade","volume":"7","author":"Natale","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ajhg.2023.05.013_bib146","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nm.2422","article-title":"Protective HIV-specific CD8+ T\u00a0cells evade Treg cell suppression","volume":"17","author":"Elahi","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib147","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1756-0381-6-18","article-title":"Visualizing genomic information across chromosomes with PhenoGram","volume":"6","author":"Wolfe","year":"2013","journal-title":"BioData Min."},{"key":"10.1016\/j.ajhg.2023.05.013_bib148","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","article-title":"Million Veteran Program: A mega-biobank to study genetic influences on health and disease","volume":"70","author":"Gaziano","year":"2016","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib149","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00000372-200308000-00003","article-title":"Tumor doubling time of cutaneous melanoma and its metastasis","volume":"25","author":"Carlson","year":"2003","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1208\/s12248-019-0302-5","article-title":"Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach","volume":"21","author":"Kay","year":"2019","journal-title":"AAPS J."},{"key":"10.1016\/j.ajhg.2023.05.013_bib151","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/pcmr.12294","article-title":"The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo","volume":"27","author":"Teulings","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib153","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1073\/pnas.91.14.6458","article-title":"Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in\u00a0vivo tumor rejection","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2023.05.013_bib154","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1073\/pnas.92.18.8125","article-title":"Immunophenotyping of melanomas for tyrosinase: implications for vaccine development","volume":"92","author":"Chen","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2023.05.013_bib155","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1084\/jem.184.6.2207","article-title":"Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes","volume":"184","author":"Wang","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib156","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910630313","article-title":"Expression of MAGE genes in primary and metastatic cutaneous melanoma","volume":"63","author":"Brasseur","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib157","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000658-199608000-00011","article-title":"Expression of MAGE genes in human colorectal carcinoma","volume":"224","author":"Mori","year":"1996","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ajhg.2023.05.013_bib158","first-page":"335","article-title":"Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers","volume":"5","author":"Scarcella","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib159","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-5002(03)00244-7","article-title":"Expression of cancer\/testis (CT) antigens in lung cancer","volume":"42","author":"Tajima","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib160","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1158\/1078-0432.CCR-05-1203","article-title":"Cancer-testis genes are coordinately expressed and are markers of poor outcome in\u00a0non-small cell lung cancer","volume":"11","author":"Gure","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib161","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-05-1544","article-title":"Tumor antigen expression in melanoma varies according to antigen and stage","volume":"12","author":"Barrow","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib162","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3892\/ijmm.2012.896","article-title":"Pattern of cancer\/testis antigen expression in lung cancer patients","volume":"29","author":"Kim","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib163","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-016-0288-x","article-title":"NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets","volume":"8","author":"Nielsen","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib164","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/0008-5472.CAN-04-0937","article-title":"Immunogenicity of constitutively active V599EBRaf","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib165","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/2326-6066.CIR-15-0030","article-title":"BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma","volume":"3","author":"Bradley","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ajhg.2023.05.013_bib166","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-94-007-2199-9_10","article-title":"Folate in Skin Cancer Prevention","volume":"56","author":"Williams","year":"2012","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ajhg.2023.05.013_bib167","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib168","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0002-9440(10)64682-2","article-title":"Expression of Microtubule-Associated Protein 2 in Benign and Malignant Melanocytes","volume":"158","author":"Fang","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib169","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1046\/j.0022-202x.2001.01563.x","article-title":"Transcriptional Repression of the Microphthalmia Gene in Melanoma Cells Correlates with the Unresponsiveness of Target Genes to Ectopic Microphthalmia-Associated Transcription Factor","volume":"117","author":"Vachtenheim","year":"2001","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib170","doi-asserted-by":"crossref","first-page":"e002071","DOI":"10.1136\/jitc-2020-002071","article-title":"HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy","volume":"9","author":"Marcu","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib171","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/jid.2011.312","article-title":"MART-1- and gp100-Expressing and -Non-Expressing Melanoma Cells Are Equally Proliferative in Tumors and Clonogenic In\u00a0Vitro","volume":"132","author":"Aris","year":"2012","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib172","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/bjc.2011.451","article-title":"TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome","volume":"105","author":"Journe","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib173","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","article-title":"Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation","volume":"8","author":"Wieczorek","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib174","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-018-0100-z","article-title":"Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases","volume":"5","author":"Bodis","year":"2018","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.ajhg.2023.05.013_bib175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI74961","article-title":"Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA","volume":"125","author":"Miyadera","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ajhg.2023.05.013_bib176","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399408000719","article-title":"Galectins: structure, function and therapeutic potential","volume":"10","author":"Yang","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ajhg.2023.05.013_bib177","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","article-title":"Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?","volume":"8","author":"Crux","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib178","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cellimm.2008.01.006","article-title":"The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T\u00a0cell and prolongs survival of skin graft","volume":"250","author":"Wang","year":"2007","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib179","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.immuni.2008.10.010","article-title":"Lytic granule loading of CD8+ T\u00a0cells is required for HIV-infected cell elimination associated with immune control","volume":"29","author":"Migueles","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.ajhg.2023.05.013_bib180","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature08997","article-title":"Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection","volume":"465","author":"Ko\u0161mrlj","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.05.013_bib181","doi-asserted-by":"crossref","first-page":"e05345","DOI":"10.7554\/eLife.05345","article-title":"Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding","volume":"4","author":"Chappell","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.ajhg.2023.05.013_bib182","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1126\/science.1195271","article-title":"The major genetic determinants of HIV-1 control affect HLA class I peptide presentation","volume":"330","author":"Pereyra","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ajhg.2023.05.013_bib183","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4049\/jimmunol.1100316","article-title":"Multilayered defense in HLA-B51-associated HIV viral control","volume":"187","author":"Zhang","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib184","doi-asserted-by":"crossref","first-page":"17203","DOI":"10.1074\/jbc.M117.806976","article-title":"The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C\u221706:02 molecule","volume":"292","author":"Mobbs","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ajhg.2023.05.013_bib185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/353321a0","article-title":"The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation","volume":"353","author":"Madden","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.05.013_bib186","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni1208","article-title":"Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum","volume":"6","author":"Saveanu","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib187","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ni859","article-title":"An IFN-\u03b3\u2013induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I\u2013presented peptides","volume":"3","author":"Saric","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib188","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ni860","article-title":"The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues","volume":"3","author":"York","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib189","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ni1409","article-title":"In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides","volume":"8","author":"Hammer","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4049\/jimmunol.1300598","article-title":"Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity","volume":"191","author":"Reeves","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ajhg.2023.05.013_bib191","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1074\/jbc.M113.529610","article-title":"Combined effects of ankylosing spondylitis-associated ERAP1 polymorphisms outside the catalytic and peptide-binding sites on the processing of natural HLA-B27 ligands","volume":"289","author":"Mart\u00edn-Esteban","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ajhg.2023.05.013_bib192","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib193","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2023.05.013_bib194","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1038\/ncomms7916","article-title":"Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility","volume":"6","author":"Yin","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.05.013_bib195","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s43018-020-00140-1","article-title":"Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44","volume":"1","author":"Cummings","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ajhg.2023.05.013_bib196","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1021\/bi00032a005","article-title":"Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population","volume":"34","author":"DiBrino","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajhg.2023.05.013_bib197","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","article-title":"Ankylosing spondylitis and HL-A 27","volume":"1","author":"Brewerton","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.ajhg.2023.05.013_bib198","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(74)91262-8","article-title":"HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis","volume":"1","author":"Brewerton","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.ajhg.2023.05.013_bib199","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2010.79","article-title":"Pathogenesis of ankylosing spondylitis","volume":"6","author":"Tam","year":"2010","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929723001702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929723001702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:23:01Z","timestamp":1762078981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929723001702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":199,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0002929723001702"],"URL":"https:\/\/doi.org\/10.1016\/j.ajhg.2023.05.013","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.12.456166","asserted-by":"object"}]},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune alleles at the major histocompatibility locus modify melanoma susceptibility","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Human Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajhg.2023.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023","name":"copyright","label":"Copyright"}]}}